Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
Abstract Background The purpose of this study was to compare the impact of intravitreal dexamethasone (DEX) implant during a 12-month period in nondiabetic and diabetic patients without diabetic retinopathy (DR) as a treatment for refractory pseudophakic cystoid macular edema (PCME) following prior...
Main Authors: | Magna Vanessa Rodrigues, Jose Mauricio Botto Garcia, Katia Delalibera Pacheco, Fabricio Tadeu Borges, David Leonardo Cruvinel Isaac, Marcos Avila |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | International Journal of Retina and Vitreous |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40942-023-00489-2 |
Similar Items
-
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
by: Jazmín Baca Moreno, et al.
Published: (2024-03-01) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
by: Ke-Ke Hu, et al.
Published: (2022-12-01) -
Intravitreal Dexamethasone Implant for the Treatment of Patient with Resistant to Anti-VEGF Diabetic Macular Edema
by: M. M. Bikbov, et al.
Published: (2020-08-01) -
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
by: Chang Ki Yoon, et al.
Published: (2021-01-01) -
Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex®) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
by: Murat Garlı, et al.
Published: (2021-12-01)